Literature DB >> 29571850

Phenotypical features of two patients diagnosed with PHARC syndrome and carriers of a new homozygous mutation in the ABHD12 gene.

Marina Frasquet1, Vincenzo Lupo2, María José Chumillas3, Juan Francisco Vázquez-Costa4, Carmen Espinós2, Teresa Sevilla5.   

Abstract

PHARC (Polyneuropathy, Hearing loss, Ataxia, Retinitis pigmentosa and Cataracts) (MIM# 612674) is an autosomal recessive neurodegenerative disease caused by mutations in the ABHD12 gene. We evaluated two Spanish siblings affected with pes cavus, sensorimotor neuropathy, hearing loss, retinitis pigmentosa and juvenile cataracts in whom the genetic test of ABHD12 revealed a novel homozygous frameshift mutation, c.211_223del (p.Arg71Tyrfs*26). The earliest clinical manifestation in these patients was a demyelinating neuropathy manifested with a Charcot-Marie-Tooth phenotype over three decades. Progressive hearing loss, cataracts and retinitis pigmentosa appeared after the age of 30. We herein describe the complete clinical picture of these two patients, and focus particularly on neuropathy characteristics. This study supports the fact that although PHARC is rare, its phenotype is very characteristic and we should include its study in patients affected with demyelinating polyneuropathy, hearing loss and retinopathy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABHD12 gene; Charcot-Marie-Tooth disease; Deaf-blindness; PHARC; Usher syndrome

Mesh:

Substances:

Year:  2018        PMID: 29571850     DOI: 10.1016/j.jns.2018.02.021

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  PHARC Syndrome, a Rare Genetic Disorder-Case Report.

Authors:  Paulo André Dias Bastos; Marcelo Mendonça; Tânia Lampreia; Marta Magriço; Jorge Oliveira; Raquel Barbosa
Journal:  Mov Disord Clin Pract       Date:  2021-07-09

Review 2.  Druggable Targets in Endocannabinoid Signaling.

Authors:  Ann M Gregus; Matthew W Buczynski
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 3.  Atypical and ultra-rare Usher syndrome: a review.

Authors:  Rosalie M Nolen; Robert B Hufnagel; Thomas B Friedman; Amy E Turriff; Carmen C Brewer; Christopher K Zalewski; Kelly A King; Talah T Wafa; Andrew J Griffith; Brian P Brooks; Wadih M Zein
Journal:  Ophthalmic Genet       Date:  2020-05-06       Impact factor: 1.803

4.  Dark-adapted threshold and electroretinogram for diagnosis of Usher syndrome.

Authors:  Lucia Ambrosio; Ronald M Hansen; Anne Moskowitz; Andrea Oza; Devon Barrett; Juliana Manganella; Genevieve Medina; Kosuke Kawai; Anne B Fulton; Margaret Kenna
Journal:  Doc Ophthalmol       Date:  2021-01-28       Impact factor: 2.379

5.  Mapping the Neuroanatomy of ABHD16A, ABHD12, and Lysophosphatidylserines Provides New Insights into the Pathophysiology of the Human Neurological Disorder PHARC.

Authors:  Shubham Singh; Alaumy Joshi; Siddhesh S Kamat
Journal:  Biochemistry       Date:  2020-06-03       Impact factor: 3.162

6.  Hiding in plain sight: genetic deaf-blindness is not always Usher syndrome.

Authors:  Genevieve Medina; Julia Perry; Andrea Oza; Margaret Kenna
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-08-02

7.  The Phenotypic Spectrum of Patients with PHARC Syndrome Due to Variants in ABHD12: An Ophthalmic Perspective.

Authors:  Xuan-Thanh-An Nguyen; Hind Almushattat; Ine Strubbe; Michalis Georgiou; Catherina H Z Li; Mary J van Schooneveld; Inge Joniau; Elfride De Baere; Ralph J Florijn; Arthur A Bergen; Carel B Hoyng; Michel Michaelides; Bart P Leroy; Camiel J F Boon
Journal:  Genes (Basel)       Date:  2021-09-11       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.